跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 38 条关于
“Ki67”
全部
38
临床试验
16
药物
2
机构
0
资讯
20
去年
Lasofoxifene Shows Promise in Neoadjuvant Breast Cancer Treatment: I-SPY 2 Trial
去年
Lasofoxifene Shows Promise in Early Breast Cancer Treatment, I-SPY 2 Trial Data Reveal
去年
Lasofoxifene Shows Promise in Neoadjuvant Breast Cancer Treatment: I-SPY 2 Trial
去年
Enzalutamide Augments Fulvestrant Efficacy in ER+/HER2- Breast Cancer: A Neoadjuvant Trial
去年
Patritumab Deruxtecan Shows Efficacy in High-Risk HR+/HER2- Breast Cancer
去年
NETTER-2 Trial: 177Lu-Dotatate Shows Promise but Raises Questions in High-Grade NETs
9个月前
BioVaxys Reports Positive Phase 1 Results for Cancer Immunotherapies in Breast and Bladder Cancer
去年
Denosumab Shows Immunomodulatory Effects in HER2-Negative Early Breast Cancer
去年
Luminal A DCIS Shows Strong Response to Letrozole in Phase II Trial, Genomic Study Reveals
去年
Novel Triple Immunotherapy Combination Shows Promise in PD-1 Resistant Gastroesophageal Cancer
第 1 页,共 2 页
上一页
下一页